Related Experiment Video
Updated: Jul 19, 2026
08:12
Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Published on: November 26, 2018
Interactions between cardiovascular treatments and anaesthesia
1Department of Anaesthesiology, Groupe Hospitalier Pittié-Salpêtrière, Paris, France.
Current Opinion in Anaesthesiology
|October 4, 2006
Summary
Perioperative management of high-risk patients requires careful consideration of cardiovascular treatments. Understanding medication effects on hemodynamics and regional circulation is key to deciding whether to continue or stop them during surgery.
Area of Science:
- Anesthesiology and Perioperative Medicine
- Cardiovascular Pharmacology
Background:
- Maintaining circulatory stability is crucial for high-risk surgical patients.
- Chronic cardiovascular medications can complicate perioperative physiological responses.
- These drugs may impair compensatory mechanisms during hemodynamic stress.
Purpose of the Study:
- To evaluate the impact of chronic cardiovascular treatments on perioperative hemodynamics.
- To determine the necessity of continuing or withdrawing cardiovascular medications in high-risk patients.
- To analyze the pharmacological effects on circulatory status and regional circulations.
Main Methods:
- Pharmacological review of common cardiovascular medications.
- Analysis of hemodynamic data in patients on chronic cardiovascular treatment.
- Assessment of physiological system interference and compensatory mechanism limitations.
Main Results:
- Cardiovascular treatments significantly affect perioperative hemodynamics.
- Specific medications can limit the body's ability to adapt to changing circulatory conditions.
- Potential benefits of certain drugs on regional circulations were identified.
Conclusions:
- Informed decisions regarding perioperative cardiovascular medication management are possible.
- Tailoring medication regimens based on pharmacology and patient hemodynamics improves outcomes.
- Optimizing perioperative circulatory stability requires a nuanced approach to cardiovascular drug management.
Related Concept Videos
01:18Cardiovascular Drugs: Classification based on Therapeutic Indications
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
01:28Cardiomyopathy VII: Pre and Post Operative Nursing Management
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
01:29Pathophysiology of Cardiac Performance
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
01:16Antianginal Drugs: Nitrates and β-Blockers
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...